Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Genetics

Topic: Genetics and APOE

Plain-language summary

Established AD risk factors, including APOE ε4 dosage and polygenic risk scores, were not associated with disease progression amyloid positive individuals who are actively declining. A mixed effects GWAS meta-analysis revealed one genome-wide significant locus on chromosome 22 (rs78369883) and 25 nominally significant loci linked with AD progression. Functional annotation, finemapping, and colocalization analyses implicated genes primarily involved in immune response, neurodegeneration (including tau pathology), brain resilience, and neurogenesis. These progression-related genes were significantly enriched in neuronal-interferon-microglial signalling pathways and normal homeostatic processes of neuronal networks, with specific enrichment in dopaminergic and inhibitory neuronal populations. These findings enhance our understanding of the biological underpinnings of AD progression, opening new avenues for therapeutic intervention.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Cohen, C. E., Fernandez, S., Yaman, U., Ehyaei, A. R., Porter, T., O'Brien, E., et al. (2025). Genetic drivers of progression in Alzheimer's disease are distinct from disease risk. medRxiv : the preprint server for health sciences. https://doi.org/10.1101/2025.11.17.25340247

Vancouver

Cohen CE, Fernandez S, Yaman U, Ehyaei AR, Porter T, O'Brien E, et al. Genetic drivers of progression in Alzheimer's disease are distinct from disease risk. medRxiv : the preprint server for health sciences. 2025. doi:10.1101/2025.11.17.25340247. PMID: 41332834.

BibTeX

@article{cohen2025-41332834,
  author  = {Cohen, Celeste E and Fernandez, Shane and Yaman, Umran and Ehyaei, Ahmad R and Porter, Tenielle and O'Brien, Eleanor and {Australian Imaging Biomarkers and Lifestyle Study} and {Alzheimer’s Disease Neuroimaging Initiative} and others},
  title   = {{Genetic drivers of progression in Alzheimer's disease are distinct from disease risk}},
  journal = {medRxiv : the preprint server for health sciences},
  year    = {2025},
  doi     = {10.1101/2025.11.17.25340247},
  pmid    = {41332834},
  url     = {https://doi.org/10.1101/2025.11.17.25340247}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 4 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multicenter collaboration left out, no data; Indexed in PubMed 2 of 2; Free to read left out, no data. 34 of the 60 points it could be judged on, which is 57 of 100. Raw total 57 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 57 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 57 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for effect reported because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 34 of the 60 points we could judge it on, which is 57 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv : the preprint server for health sciences)
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 222 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 A review of other studies — randomization is not credited here
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41332834)
Free to read — / 2 Access not recorded — left out of this score
Points 34 / 60 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 34 of the 60 points we could judge it on is 57 out of 100.
Total 57 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Genetics from nearby years

Also tagged “genetics”

346 studies in the library carry the topic tag “genetics”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 346 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Genetics

See all studies in Genetics →